Page last updated: 2024-08-22

betamethasone-17,21-dipropionate and Carpal Tunnel Syndrome

betamethasone-17,21-dipropionate has been researched along with Carpal Tunnel Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Barbaud, A; Bataille, P; Chasset, F; De Risi-Pugliese, T; Monfort, JB; Senet, P1
Aksoy, C; Aydin, T; Dernek, B; Diracoglu, D; Kesiktas, FN; Koseoglu, PK; Yesilyurt, T1

Trials

1 trial(s) available for betamethasone-17,21-dipropionate and Carpal Tunnel Syndrome

ArticleYear
Comparison of the efficacy of lidocaine and betamethasone dipropionate in carpal tunnel syndrome injection.
    Journal of back and musculoskeletal rehabilitation, 2017, Volume: 30, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Anesthetics, Local; Anti-Inflammatory Agents; Betamethasone; Carpal Tunnel Syndrome; Female; Humans; Lidocaine; Male; Middle Aged; Physical Examination; Steroids

2017

Other Studies

1 other study(ies) available for betamethasone-17,21-dipropionate and Carpal Tunnel Syndrome

ArticleYear
[Linear cutaneous hypopigmentation and atrophy associated with intralesional steroid injection for carpal tunnel syndrome].
    Annales de dermatologie et de venereologie, 2020, Volume: 147, Issue:4

    Topics: Atrophy; Betamethasone; Carpal Tunnel Syndrome; HIV Infections; Humans; Hypopigmentation; Injections; Injections, Intralesional; Male; Middle Aged; Skin Diseases

2020